Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15

Huiyuan Zhu(Shaanxi University of Chinese Medicine), Huanlong Qin(Tongji University)
Nature Communications
February 24, 2024
10.1038/s41467-024-45572-w
Cited by 73

Related Papers

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
|Signal Transduction and Targeted Therapy|2021|279
Randomized clinical trial to compare the effects of preoperative oral carbohydrate <i>versus</i> placebo on insulin resistance after colorectal surgery
|British journal of surgery|2010|169